| Product NDC: | 11673-527 |
| Proprietary Name: | Loratadine |
| Non Proprietary Name: | Loratadine |
| Active Ingredient(s): | 10 mg/1 & nbsp; Loratadine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 11673-527 |
| Labeler Name: | Target Corporation |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | ANDA077153 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070831 |
| Package NDC: | 11673-527-31 |
| Package Description: | 1 BLISTER PACK in 1 CARTON (11673-527-31) > 30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| NDC Code | 11673-527-31 |
| Proprietary Name | Loratadine |
| Package Description | 1 BLISTER PACK in 1 CARTON (11673-527-31) > 30 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| Product NDC | 11673-527 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | Loratadine |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20070831 |
| Marketing Category Name | ANDA |
| Labeler Name | Target Corporation |
| Substance Name | LORATADINE |
| Strength Number | 10 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes |